Nutex Health (NUTX) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for April 23, 2026, to be held virtually, allowing global participation and online voting.

• Proxy materials and annual report are distributed electronically to reduce costs and environmental impact, with options for printed copies upon request.

• Record date for voting is February 27, 2026, with 5,628,591 shares of common stock outstanding and entitled to vote.

Voting matters and shareholder proposals

• Shareholders will vote on re-election of seven directors for one-year terms, an advisory say-on-pay vote on executive compensation, and ratification of Grant Thornton LLP as independent auditor for 2026.

• Shareholders may submit proposals for the 2027 meeting by January 27, 2027, and can nominate directors following advance notice procedures.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of seven members, with a mix of independent and non-independent directors; independence determined per NASDAQ and SEC rules.

• Board committees include Audit, Compensation, and Nominating and Governance, each with written charters and independent membership.

• Board met 15 times in 2025; committee meetings held regularly.

• Board leadership structure allows flexibility; currently, CEO also serves as Chairman.

• Code of Business Ethics, Insider Trading, and Anti-Hedging policies are in place.